A trial of the Oxford-AstraZeneca COVID vaccine on children in the UK has been paused while the medicines regulator investigates a possible link between the jab and rare blood clots in adults.

A University of Oxford spokesperson stressed that there were “no safety concerns” with this specific study, but that further information was being awaited from the Medicines and Healthcare products Regulatory Agency (MHRA).

“Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial,” the statement said.

“Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions.”

Related posts:

‘Appalling scenes’: Parks forced to close as sunseekers brawl and leave behind piles of rubbish Crime victims have right to know when offender is leaving jail, as new code comes in Teenager arrested after man fatally stabbed at London shopping centre Last two rounds of Premier League fixtures only open to home fans BAFTA defends decision to present Noel Clarke with outstanding contribution to cinema award Sterling racially abused less than 48 hours after football social media boycott ends UK reports 26,476 new daily COVID-19 cases and another 48 deaths ‘I drank a bottle of Lucozade from the Queen’s fridge’ – the day Batman broke into the grounds of Buckingham Palace Thousands of homes still without power after Storm Arwen causes some of the ‘worst’ disruption in 20 years 100,000 critical workers to take daily COVID tests in bid to ease Omicron shortages ‘Very real possibility’ man accused of assaulting Chris Whitty could be jailed Ex-Olympic showjumping coach sexually abused teenage girl over seven-year period, court told